How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

8,693 results for

Chemical Dependency Management

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Chemical Dependency Management

Chemical Dependency Management Chemical Dependency Management Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Chemical Dependency (...) Management Chemical Dependency Management Aka: Chemical Dependency Management From Related Chapters II. Management See See See See See Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Chemical Dependency Management." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip Database) Related Topics in Chemical Dependency About FPnotebook.com is a rapid access, point-of-care

2018 FP Notebook

2. Trauma (chemical)

Trauma (chemical) Trauma (chemical) submit The College submit You're here: Trauma (chemical) Trauma (chemical) The CMGs are guidelines on the diagnosis and management of a range of common and rare, but important, eye conditions that present with varying frequency in primary and first contact care. Share options Aetiology The incidence of chemical injuries to the eye has been reported to be 10.7 per 100,000 population per annum, representing an estimated 10% of ocular trauma treated in emergency (...) . After this first aid, the optometrist will arrange for the ophthalmologist to see the patient as soon as possible on the same day. Depending on the severity of the injury, the ophthalmologist may admit the patient to hospital for further intensive treatment. Trauma (chemical) Version 10 Date of search 17.08.17 Date of revision 30.01.18 Date of publication 09.05.18 Date for review 16.08.19 © College of Optometrists View more Also in this section The College of Optometrists 42 Craven Street London

2018 College of Optometrists

3. Skin changes suggestive of chemical dependency

Skin changes suggestive of chemical dependency Skin changes suggestive of chemical dependency Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer (...) Administration 4 Skin changes suggestive of chemical dependency Skin changes suggestive of chemical dependency Aka: Skin changes suggestive of chemical dependency , Dermatologic findings in chemical dependency II. Findings "Pop" Scars from s (esp. , ) Abscesses, Infections, or Ulcerations Infective or chemical reactions Dominant thumb is burned in crack abuse (lighter) Paint or oil stains ( ) Clothing Skin s Skin tracks or related scars Marks are multiple, hyperpigmented and linear New lesions may

2018 FP Notebook

4. Chemical Dependency Resources

Chemical Dependency Resources Chemical Dependency Resources Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Chemical Dependency (...) Resources Chemical Dependency Resources Aka: Chemical Dependency Resources , Substance Abuse Resources From Related Chapters II. Resources: Addiction Information SAMHSA Helpline National Institute on (NIDA) III. Resources: Addiction Treatment and Support Programs Al-Anon and Alateen ics Anonymous Anonymous s Anonymous IV. Resources: Facility and Physician Locators SAMHSA Treatment Facility Locator American Society of Addiction Medicine Treatment Links Images: Related links to external sites (from Bing

2018 FP Notebook

5. Chemical Dependency

Chemical Dependency Chemical Dependency Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Chemical Dependency Chemical Dependency Aka (...) : Chemical Dependency , Chemical Dependence , Drug Dependence , Chemical Intoxication , Intoxication , Substance Abuse , Substance Misuse , Drug Abuse , AODA , Drugs of Abuse From Related Chapters II. Epidemiology (2015, U.S. over age 10 years old): 10% Teenagers <14 years old who use substances will have a 33% risk of substance use disorder longterm Substance use goes undiagnosed in 43% of cases in the primary care setting III. Preparations: Primary abused substances Precautions Substances of abuse

2018 FP Notebook

6. Eye Examination Signs of Chemical Dependency

Eye Examination Signs of Chemical Dependency Eye Examination Signs of Chemical Dependency Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer (...) Administration 4 Eye Examination Signs of Chemical Dependency Eye Examination Signs of Chemical Dependency Aka: Eye Examination Signs of Chemical Dependency , Substance-Induced Eye Findings II. Exam: Observation Blank stare Glazing (film over ) Excessive ( ) Red ( , inhalant) Walleye or Bug-eye appearance ( ) ( ) Swelling of s ( or ) Retracted upper lid ( ) III. Exam: Pupil size and response ( ) s ( , ) (e.g. s) s ( , PCP) ( ) s (e.g. , ) s (e.g. s) Slow, delayed, sluggish or absent pupil response IV. Exam

2018 FP Notebook

7. Chemical Dependency Brief Counseling

Chemical Dependency Brief Counseling Chemical Dependency Brief Counseling Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Chemical (...) Dependency Brief Counseling Chemical Dependency Brief Counseling Aka: Chemical Dependency Brief Counseling , Counseling Briefly for Cessation of Chemical Use , FRAMES Technique II. Indication Brief counseling by primary physician III. Protocol: Example for Alcohol use Initial physician visit for 15 minutes Use What are drinking triggers for this patient? Review risks for this patient for continued use Set specific goals for cessation or reduction Patient's personal responsibility Determine schedule

2018 FP Notebook

8. An overview of physico-chemical mechanisms of biogas production by microbial communities: a step towards sustainable waste management (PubMed)

An overview of physico-chemical mechanisms of biogas production by microbial communities: a step towards sustainable waste management Biogas is a combination of methane, CO2, nitrogen, H2S and traces of few other gases. Almost any organic waste can be biologically transformed into biogas and other energy-rich organic compounds through the process of anaerobic digestion (AD) and thus helping in sustainable waste management. Although microbes are involved in each step of AD, knowledge about those (...) (mainly unculturable), the remaining being thermophilic microbes. Thus, the AD process as a whole could be controlled by regulating the microbial consortia involved in it. Optimization in the feedstock, pH, temperature and other physical parameters would be beneficial for the microbial growth and viability and thus helpful for biogas production in AD. Besides, the biogas production is also dependent upon the activity of several key genes, ion-specific transporters and enzymes, like genes coding

Full Text available with Trip Pro

2016 3 Biotech

9. Urinary incontinence and pelvic organ prolapse in women: management

Urinary incontinence and pelvic organ prolapse in women: management Urinary incontinence and pelvic organ Urinary incontinence and pelvic organ prolapse in women: management prolapse in women: management NICE guideline Published: 2 April 2019 nice.org.uk/guidance/ng123 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view (...) in this guideline should be interpreted in a way that would be inconsistent with complying with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Urinary incontinence and pelvic organ prolapse in women: management (NG123) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines

10. British guideline on the management of asthma

British guideline on the management of asthma SIGN158 British guideline on the management of asthma A national clinical guideline First published 2003 Revised edition published July 2019Key to evidence statements and recommendations Levels of evidence 1 ++ High-quality meta-analyses, systematic reviews of RCTs, or RCTs with a very low risk of bias 1 + Well-conducted meta-analyses, systematic reviews, or RCTs with a low risk of bias 1 – Meta-analyses, systematic reviews, or RCTs with a high risk (...) (www.sign.ac.uk/sign-50). More information on accreditation can be viewed at www.evidence.nhs.ukBritish guideline on the management of asthma A national clinical guideline First published 2003 Revised edition published July 2019 Scottish Intercollegiate Guidelines Network British Thoracic Society 978-1-909103-70-2 First published 2003 Revised edition published July 2019 Scottish Intercollegiate Guidelines Network Gyle Square, 1 South Gyle Crescent Edinburgh EH12 9EB www.sign.ac.uk British Thoracic Society 17

2019 SIGN

11. Managing opioid use disorder in primary care: PEER simplified guideline

. Methadone program. Ottawa, ON: Government of Canada; 2017. Available from: www.canada.ca/en/health-canada/services/health-concerns/controlled-substances- precursor-chemicals/exemptions/methadone-program.html. Accessed 2019 Mar 10. 18. Bruneau J, Ahamad K, Goyer MÉ, Poulin G, Selby P, Fischer B, et al. Management of opioid use disorders: a national clinical practice guideline. CMAJ 2018;190:E247-57. 19. Allan GM, Lindblad AJ, Comeau A, Coppola J, Hudson B, Mannarino M, et al. Simplified lipid guidelines (...) Managing opioid use disorder in primary care: PEER simplified guideline Vol 65: MAY | MAI 2019 | Canadian Family Physician | Le Médecin de famille canadien 321 CLINICAL PRACTICE GUIDELINES Editor’s key points ? This simplified guideline for managing opioid use disorder (OUD) was developed with a primary care focus using a systematic review of systematic reviews design. Recommendations are accompanied by practice pearls and additional resources to support primary care practitioners and shared

2019 CPG Infobase

12. Asthma: diagnosis, monitoring and chronic asthma management

Asthma: diagnosis, monitoring and chronic asthma management Asthma: diagnosis, monitoring and Asthma: diagnosis, monitoring and chronic asthma management chronic asthma management NICE guideline Published: 29 November 2017 nice.org.uk/guidance/ng80 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guideline represent the view of NICE, arrived (...) be interpreted in a way that would be inconsistent with complying with those duties. Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Asthma: diagnosis, monitoring and chronic asthma management (NG80) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2

2017 National Institute for Health and Clinical Excellence - Clinical Guidelines

13. Benzene: health effects, incident management, and toxicology

Benzene: health effects, incident management, and toxicology PHE publications gateway number: 2014790 Published: October 2016 Benzene General Information Key Points • benzene is a colourless, volatile liquid with a characteristic sweet odour • it is an important chemical required for the manufacture of a wide range of materials including plastics, foams, dyes, detergents, solvents, and insecticides • major sources of benzene include vehicle exhaust, evaporation of petrol, petrol manufacturing (...) to benzene how might it affect my health? The presence of benzene in the environment does not always lead to exposure. In order for it to cause any adverse health effects you must come into contact with it. You may be exposed to benzene by breathing or ingesting the substance, or by skin or eye contact. Compendium of Chemical Hazards: Benzene Page 3 of 4 General Information Following exposure to any chemical, the adverse health effects you may encounter depend on several factors, including the amount

2019 Public Health England

14. Management of Blood Borne Viruses within the Haemodialysis Unit

Management of Blood Borne Viruses within the Haemodialysis Unit Clinical Practice Guideline Management of Blood Borne Viruses within the Haemodialysis Unit Authors: Dr Elizabeth Garthwaite – Chair Consultant Nephrologist, Leeds Teaching Hospitals NHS Trust Dr Veena Reddy Consultant Nephrologist, Sheffield Teaching Hospitals NHS Foundation Trust Dr Sam Douthwaite Consultant Virologist, Guy’s and St. Thomas’ NHS Trust, London Dr Simon Lines Consultant Nephrologist, Norwich and Norfolk University (...) included recommendations related to hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infection [3]. The Renal Association Clinical Guidelines on the management of blood borne viruses within the renal unit were published in 2008. These have been revised and updated based on a small body of clinical evidence identified by on-line literature searching of PubMed from 1966 - 2018. Search terms used included haemodialysis, hemodialysis, hepatitis, HIV, transmission, immunisation, vaccination

2019 Renal Association

15. Guidelines on Supraventricular Tachycardia (for the management of patients with)

Guidelines on Supraventricular Tachycardia (for the management of patients with) 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC) | European Heart Journal | Oxford Academic ') We use cookies to enhance your experience on our website.By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie (...) settings at any time. Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close mobile search navigation Article Navigation Article Contents Article Navigation 2019 ESC Guidelines for the management of patients with supraventricular tachycardia The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC): Developed in collaboration with the Association for European

Full Text available with Trip Pro

2019 European Society of Cardiology

16. Management of Dyslipidaemias

Management of Dyslipidaemias 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk | European Heart Journal | Oxford Academic ') We use cookies to enhance your experience on our website.By continuing to use our website, you are agreeing to our use of cookies. You can change your cookie settings at any time. Search Account Menu Menu Navbar Search Filter Mobile Microsite Search Term Close search filter search input Article Navigation Close (...) mobile search navigation Article Navigation Article Contents Article Navigation 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk : The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) François Mach Chairperson Switzerland Corresponding authors: François Mach, Cardiology Department, Geneva University Hospital, 4 Gabrielle-Perret-Gentil, 1211 Geneva

Full Text available with Trip Pro

2019 European Society of Cardiology

17. Management of Cancer Medication-Related Infusion Reactions

with a drug’s mechanism of action. 1,2 The incidence of IRs varies depending on the anticancer agent used. In some cases, the incidence of reactions may be low but the risk for potentially life-threatening reactions exists. 2,3 Most IRs occur within the first hour of either the first or second administration of an intravenous anticancer medication; therefore, careful monitoring during infusion initiation is necessary to detect potential IRs and manage accordingly. 3 In cases where IRs may be prevented (...) the first day of administration. 8 Management of Cancer Medication-Related Infusion Reactions 7 Hypersensitivity reactions (HSRs) are a subset of IRs that occur at doses normally tolerated by patients and are not consistent with a known toxicity of the drug. 2 HSRs can be divided into subtypes as defined by Gell and Coombs, depending on the mechanism of reaction. • Type I reactions are those mediated by immunoglobulin E (IgE) antibodies, and include anaphylaxis, a type of systemic HSR that is severe

2019 Cancer Care Ontario

18. Knowledge, attitude and practice related to chemical hazards and personal protective equipment among particleboard workers in Ethiopia: a cross-sectional study. (PubMed)

regarding chemical hazards and PPE.The findings revealed that permanent workers have higher proportion of positive response on knowledge and attitude towards chemical health hazards than temporary workers. However, practice in use of PPE depended on access to PPE. Few temporary workers were provided with PPE. (...) Knowledge, attitude and practice related to chemical hazards and personal protective equipment among particleboard workers in Ethiopia: a cross-sectional study. Work in the wood industry is often associated with exposure to wood dust and formaldehyde. The aims of this study were to describe the Knowledge, Attitude and Practice (KAP) concerning chemical health hazards among particleboard workers and to compare the KAP among temporary and permanent workers.A cross-sectional study design was used

Full Text available with Trip Pro

2019 BMC Public Health

19. Quality indicators for the management of head and neck squamous cell carcinoma

Quality indicators for the management of head and neck squamous cell carcinoma 2018 www.kce.fgov.be KCE REPORT 305 QUALITY INDICATORS FOR THE MANAGEMENT OF HEAD AND NECK SQUAMOUS CELL CARCINOMA 2018 www.kce.fgov.be KCE REPORT 305 HEALTH SERVICES RESEARCH QUALITY INDICATORS FOR THE MANAGEMENT OF HEAD AND NECK SQUAMOUS CELL CARCINOMA ROOS LEROY, CINDY DE GENDT, SABINE STORDEUR, GEERT SILVERSMIT, LEEN VERLEYE, VIKI SCHILLEMANS, ISABELLE SAVOYE, KATRIJN VANSCHOENBEEK, JOAN VLAYEN, LIESBET VAN (...) EYCKEN, CLAIRE BEGUIN, CÉCILE DUBOIS, LAURENS CARP, JAN CASSELMAN, JEAN- FRANÇOIS DAISNE, PHILIPPE DERON, MARC HAMOIR, ESTHER HAUBEN, OLIVIER LENSSEN, SANDRA NUYTS, CARL VAN LAER, JAN VERMORKEN, VINCENT GRÉGOIRE COLOPHON Title: Quality indicators for the management of head and neck squamous cell carcinoma Authors: Roos Leroy (KCE), Cindy De Gendt (Stichting Kankerregister), Sabine Stordeur (KCE), Geert Silversmit (Stichting Kankerregister), Leen Verleye (KCE), Viki Schillemans (Stichting

2019 Belgian Health Care Knowledge Centre

20. Medical management of abortion

-effectiveness. Studies on medical abortion include analgesic options ranging from oral to parenteral administration, including opiates, depending on gestational age. In cases where additional An enabling regulatory and policy environment is needed to ensure that every individual who can become pregnant and who is legally eligible has ready access to safe abortion care.28 Recommendations hospital resources are required, such as blood transfusion, inpatient management, analgesic measures or foeticide, we (...) Medical management of abortion A Medical management of abortionMedical management of abortion, 2018 ISBN 978-92-4-155040-6 © World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https:// creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work

2019 World Health Organisation Guidelines

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>